A new trading day began on Tuesday, with Tenaya Therapeutics Inc (NASDAQ: TNYA) stock price down -6.02% from the previous day of trading, before settling in for the closing price of $1.66. TNYA’s price has ranged from $0.36 to $4.01 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -15.48%. Meanwhile, its annual earnings per share averaged 47.83%. With a float of $136.10 million, this company’s outstanding shares have now reached $162.98 million.
Tenaya Therapeutics Inc (TNYA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tenaya Therapeutics Inc is 16.49%, while institutional ownership is 17.25%. The most recent insider transaction that took place on Aug 18 ’25, was worth 3,711. In this transaction SVP, Finance of this company sold 2,962 shares at a rate of $1.25, taking the stock ownership to the 95,338 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Chief Medical Officer sold 5,053 for $1.25, making the entire transaction worth $6,331. This insider now owns 172,803 shares in total.
Tenaya Therapeutics Inc (TNYA) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.3 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.83% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Here are Tenaya Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
The latest stats from [Tenaya Therapeutics Inc, TNYA] show that its last 5-days average volume of 3.79 million was superior to 3.18 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 8.99%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 56.42%, which indicates a significant increase from 1.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1700 in the past 14 days, which was higher than the 0.1023 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4912, while its 200-day Moving Average is $0.9117. Now, the first resistance to watch is $1.6233. This is followed by the second major resistance level at $1.6867. The third major resistance level sits at $1.7233. If the price goes on to break the first support level at $1.5233, it is likely to go to the next support level at $1.4867. The third support level lies at $1.4233 if the price breaches the second support level.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
With a market capitalization of 254.24 million, the company has a total of 162,976K Shares Outstanding. Currently, annual sales are 0 K while annual income is -111,130 K. The company’s previous quarter sales were 0 K while its latest quarter income was -23,280 K.
